Chhattisgarh sterilisation deaths: Govt asked to recall spurious drug from state health centres Raipur, Nov 2014: Indian women who underwent sterilization surgeries receive treatment at the District Hospital in Bilaspur, in the central Indian state of Chhattisgarh, Wednesday, Nov. 12, 2014, after at least a dozen died and many others fell ill following similar surgery.
Acting on a petition by the Chhattisgarh Congress, the Bilaspur High Court on Monday directed the Raman Singh government to withdraw the Ciprofloxacin medicine of Mahawar Pharma Ltd from all health centres in the state.
Brief update on some recent Drugs Banned in India A number of individual drugs as well as fixed dose combinations are banned in India. Drugs undergo rigorous testing before they are introduced into the market. They are first tested in animals and then in human beings during clinical trials. The efficacy as well as safety profiles of the drug are tested. In spite of this, some adverse effects of drugs appear only after the drug is used in the general population. These adverse effects are detected though a process of regular monitoring after the drug is released called pharmacovigilance. If the adverse effects are severe or the risks of using the drug outweigh the benefits, or if the drug is ineffective, the country may ban the drug or the Drug Company may itself voluntarily withdraw the drug. Some drugs may cause adverse effects only when combined with particular drugs.
FDA approves Avastin for ovarian cancer
NOVEMBER, 2014: Roche has garnered a new indication for Avastin from US regulators, this time in combination with chemotherapy for the treatment of women with platinum-resistant, recurrent ovarian cancer.
FDA Warns About Undeclared Drugs Found in Weight-Loss Product
NOVEMBER, 2014: FDA is advising consumers not to purchase or use Sit and Slim II, promoted and sold as a dietary supplement with weight loss claims. Sit and Slim II has been found to contain undeclared phenolphthalein, sibutramine or a combination of both, which makes it an unapproved drug. Sibutramine was a controlled, FDA-approved substance for the treatment of obesity until it was removed from the U.S. market in 2010 for safety reasons. Phenolphthalein, once used in over-the-counter laxatives, is also not approved for marketing in the U.S. because of concerns that the substance can cause cancer.
How to Stay Safe as A Patient
Patients are growing concerned about reports of counterfeit drugs being provided by doctors. In February, 19 U.S. cancer clinics were warned by the FDA that they had received counterfeit versions of a cancer drug. Patients can protect themselves by asking their physicians questions about the origins of medicines they receive in their doctor's office. Authentic Avastin is made in the U.S. and moves through a closed, secure drug supply chain to American cancer clinics. The counterfeit medication, however, crossed four continents before arriving in the U.S. via unauthorized distributors. Investigators are working to identify those responsible for manufacturing this fake medicine. One thing they do know is that the fake product was not the vital, lifesaving chemotherapy patients expected.
Frequently Asked Questions Q1. What is meant by a blood bank?
Answer:A place or organization or unit or institution or other arrangements made by such organization, unit or institution for carrying out all or any of the operation for collection, apheresis, storage, processing and distribution of blood drawn from donor for preparation, storage & distribution of blood components. A blood bank may be a separate free-standing facility or part of a larger laboratory in a hospital.
Typically, each donated unit of blood (whole blood) is separated into multiple components. Each component is generally transfused to a different individual, each with different needs. Generally components like Packed red blood cells, Platelet concentrate, Fresh Frozen Plasma (FFP), washed red cells, Cryoprecipitate, granulocyte concentrate etc. are prepared from collected blood.
In India, blood bank license issued by the State Licensing Authority (DC) & approved by the Central License Approving Authority (DCGI) is required for functioning of a blood bank.
Q2. What are the conditions for Blood donor selection followed In India?
Answer:The general conditions which are looked for in donors are-
• Age ----Between 18-60 years
• Haemoglobin------not less than 12.5gm%
• Blood-----Systolic 100-180 mm of Hg
• Diastolic-----50-100 mm of Hg
• Body weight------not less than 45 Kg
Donor should be in a healthy state mind and body and they should also fulfill the following criteria-
➢ Past 1 year-----not been treated for Rabies
➢ Hepatitis & immunoglobulin-----Past 6 months